Common Stock, Shares, Outstanding of Vincerx Pharma, Inc. from 30 Jun 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Vincerx Pharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Jun 2019 to 31 Mar 2025.
  • Vincerx Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Mar 2025 was 5,234,277, a 76% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Vincerx Pharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 5,234,277 -16,179,112 -76% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 2,239,580 +1,169,205 +109% 31 Dec 2024 10-Q 15 May 2025 2025 Q1
Q3 2024 31,395,903 +10,015,333 +47% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 29,671,903 +8,291,333 +39% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 21,413,389 +167,547 +0.79% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 1,070,375 -20,172,509 -95% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 21,380,570 +190,801 +0.9% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 21,380,570 +190,801 +0.9% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 21,245,842 +188,282 +0.89% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 21,242,884 +185,324 +0.88% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 21,189,769 +168,694 +0.8% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 21,189,769 +3,668,694 +21% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 21,057,560 +6,361,641 +43% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 21,057,560 +7,073,119 +51% 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q3 2021 21,021,075 +18,579,874 +761% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 17,521,075 +15,123,305 +631% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 14,695,919 +12,308,903 +516% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 13,984,441 +8,788,441 +169% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 2,441,201 30 Sep 2020 10-Q 10 Nov 2020 2021 Q1
Q2 2020 2,397,770 +960,270 +67% 30 Jun 2020 10-Q 10 Nov 2020 2021 Q1
Q1 2020 2,387,016 31 Mar 2020 10-Q 06 May 2020 2020 Q3
Q4 2019 5,196,000 31 Dec 2019 10-K/A 14 May 2021 2020 FY
Q2 2019 1,437,500 30 Jun 2019 10-K 23 Sep 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.